Founded in 1996 as a small family business, Erchonia has grown into an international enterprise while staying true to its core principles. Dedicated to advancing Low-Level Laser Therapy (3LT®) through rigorous scientific and clinical research, Erchonia has become a world leader in LLLT technology. With a steadfast commitment to quality and integrity, the company transforms research hypotheses into agency-approved products and treatment methods. As a manufacturer, developer, promoter, and user of its own technologies, Erchonia delivers innovative solutions driven by excellence and a passion for advancing healthcare.